FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christine Luise Kempton

Research Profile

Chemicals & Drugs

Disorders

Physiology

Co-author Network

Publications

TOP 3
S L Meeks; Christine Luise Kempton; R L Chapman; Amy L Dunn
Late immune tolerance induction in haemophilia A patients.
Christine Luise Kempton; C M Kessler; Nigel S Key; B A Konkle; P Kuriakose; D E Macfarlane; Thomas C Abshire; R A Deveras; J C Gill; W K Hoots; G Bergman
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A.
Ryan J Summers; Shannon L Meeks; John Francis Healey; Harrison C Brown; Ernest T Parker; Christine Luise Kempton; Christopher B Doering; Pete Lollar
Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional protein.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christine Luise Kempton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: S L Meeks; Christine Luise Kempton; R L Chapman; Amy L Dunn
Late immune tolerance induction in haemophilia A patients.
Haemophilia : the official journal of the World Federation of Hemophilia 2013;19(3):445-8.
2012: Christine Luise Kempton; C M Kessler; Nigel S Key; B A Konkle; P Kuriakose; D E Macfarlane; Thomas C Abshire; R A Deveras; J C Gill; W K Hoots; G Bergman
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(5):798-804.
2011: Ryan J Summers; Shannon L Meeks; John Francis Healey; Harrison C Brown; Ernest T Parker; Christine Luise Kempton; Christopher B Doering; Pete Lollar
Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional protein.
Blood 2011;117(11):3190-8.
2011: Christine Luise Kempton; S L Meeks; R Donald Harvey; T C Abshire
Evaluation of factor VIII pharmacokinetics and anti-factor VIII antibodies in four boys with haemophilia A and a poor clinical response to factor VIII.
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(1):155-6.
2010: Christine Luise Kempton; J Michael Soucie; C H Miller; C Hooper; M A Escobar; A J Cohen; N S Key; A R Thompson; Thomas C Abshire
In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case-control study.
Journal of thrombosis and haemostasis : JTH 2010;8(10):2224-31.
2010: Christine Luise Kempton
Inhibitors in previously treated patients: a review of the literature.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16(102):61-5.
2009: Christine Luise Kempton; Gilbert C White
How we treat a hemophilia A patient with a factor VIII inhibitor.
Blood 2009;113(1):11-7.
2008: fania szlam; Taro Taketomi; Chelsea A Sheppard; Christine Luise Kempton; Jerrold H Levy; Kenichi A Tanaka
Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
Anesthesia and analgesia 2008;106(3):719-24, table of contents.
2006: Christine Luise Kempton; J Michael Soucie; Thomas C Abshire
Incidence of inhibitors in a cohort of 838 males with hemophilia A previously treated with factor VIII concentrates.
Journal of thrombosis and haemostasis : JTH 2006;4(12):2576-81.
2006: Jorge Di Paola; Louis M Aledort; H Britton; Manuel Carcao; E Grabowski; J Hutter; J Journeycake; Christine Luise Kempton; C Leissinger
Application of current knowledge to the management of bleeding events during immune tolerance induction.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(6):591-7.
2006: Christine Luise Kempton; R Donald Harvey; Harold R Roberts
Novel therapeutic agents in the management of hemorrhage and thrombosis.
Cardiovascular & hematological agents in medicinal chemistry 2006;4(4):319-34.
2005: G C White; Christine Luise Kempton; A Grimsley; B Nielsen; Harold R Roberts
Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?
Journal of thrombosis and haemostasis : JTH 2005;3(8):1676-81.
2005: Christine Luise Kempton; Maureane Hoffman; Harold R Roberts; Dougald M Monroe
Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(4):861-6.
2004: Christine Luise Kempton; Miguel A Escobar; Harold R Roberts
Hemophilia care in the 21st century.
Clinical advances in hematology & oncology : H&O 2004;2(11):733-40.
2001: Christine Luise Kempton; Grover C Bagby; Judith F Collins
Ulcerative colitis presenting as purpura fulminans.
Inflammatory bowel diseases 2001;7(4):319-22.
1997: Christine Luise Kempton; Paul J Kurtin; David J Inwards; P Wollan; D G Bostwick
Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma.
The American journal of surgical pathology 1997;21(11):1324-33.